Skip to main content
Fig. 4 | Molecular Cancer

Fig. 4

From: Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways

Fig. 4

Syndecan-1 silencing suppresses CSC-related gene expression in SUM-149 and SKBR3 cells. Post Syndecan-1 knockdown, total RNA isolated from SUM-149 (a) and SKBR3 cells (b) was reverse transcribed into cDNA and subjected into qPCR. Data represent mean ± SEM, n ≥ 3. * P < 0.05, # P < 0.01 as determined by Student’s t-test

Back to article page

Molecular Cancer

ISSN: 1476-4598